Bronchial thermoplasty: A new treatment for severe refractory asthma

Cleveland Clinic Journal of Medicine

Volumn 78, Issue 7, 2011, Pages 477-485

  Gildea, Thomas R ^a   Khatri, Sumita B ^a   Castro, Mario ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ASTHMA; BRONCHOSCOPY; BRONCHUS; CATHETER ABLATION; CLINICAL PROTOCOL; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; INSTRUMENTATION; REVIEW; SMOOTH MUSCLE; TREATMENT FAILURE;

ADRENAL CORTEX HORMONES; ASTHMA; BRONCHI; BRONCHOSCOPY; CATHETER ABLATION; CLINICAL PROTOCOLS; FORCED EXPIRATORY VOLUME; HUMANS; MUSCLE, SMOOTH; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE;

EID: 79960132276     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.78a.10185     Document Type: Review

References (25)

1. Danek CJ, Lombard CM, Dungworth DL, et al. Reduction in airway hyperresponsiveness to methacholine by the application of RF energy in dogs. J Appl Physiol 2004; 97:1946-1953.
2. Miller JD, Cox G, Vincic L, Lombard CM, Loomas BE, Danek CJ. A prospective feasibility study of bronchial thermoplasty in the human airway. Chest 2005; 127:1999-2006.
3. US Food and Drug Administration (FDA). Approval of Alair Bronchial Thermoplasty System: Alair Catheter and Alair RF Controller. 2010. www.accessdata.fda.gov/cdrh_docs/pdf8/P080032a.pdf. Accessed June 1, 2011.
4. Cox G, Thomson NC, Rubin AS, et al; AIR Trial Study Group. Asthma control during the year after bronchial thermoplasty. N Engl J Med 2007; 356:1327-1337.
5. Pavord ID, Cox G, Thomson NC, et al; RISA Trial Study Group. Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am J Respir Crit Care Med 2007; 176:1185-1191.
6. Castro M, Rubin AS, Laviolette M, et al; AIR2 Trial Study Group. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med 2010; 181:116-124.
7. Centers for Disease Control and Prevention. Vital signs: asthma prevalence, disease characteristics, and self-management education- United States, 2001-2009. MMWR Morb Mortal Wkly Rep 2011; 60(17):547-552.
8. Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report. J Allergy Clin Immunol 1991; 88:425-534.
9. US Department of Health and Human Services; National Heart, Lung, and Blood Institute; National Institutes of Health. Expert panel report 2 (EPR-2): Guidelines for the diagnosis and management of asthma, 1997. www.nhlbi.nih.gov/guidelines/archives/epr-2/ index.htm. Accessed June 1, 2011.
10. US Department of Health and Human Services; National Heart, Lung, and Blood Institute; National Institutes of Health. Expert panel report: Guidelines for the diagnosis and management of asthma-Update on selected topics 2002. www.nhlbi.nih.gov/guidelines/ archives/epr-2_upd/index.htm. Accessed June 1, 2011.
11. Akinbami L. Asthma prevalence, health care use and mortality: United States 2003-05, CDC National Center for Health Statistics, 2006. www.cdc.gov/nchs/data/hestat/asthma03-05/asthma03-05.htm. Accessed June 1, 2011.
12. US Department of Health and Human Services; National Heart, Lung, and Blood Institute; National Institutes of Health. Expert panel report 3 (EPR-3): Guidelines for the diagnosis and management of asthma full report, 2007. www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed June 1, 2011.
13. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 2000; 162:2341-2351.
14. Moore WC, Bleecker ER, Curran-Everett D, et al; National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007; 119:405-413.
15. Ambrogi MC, Fanucchi O, Lencioni R, Cioni R, Mussi A. Pulmonary radiofrequency ablation in a single lung patient. Thorax 2006; 61:828-829.
16. Benussi S, Cini R, Gaynor SL, Alfieri O, Calafiore AM. Bipolar radiofrequency maze procedure through a transseptal approach. Ann Thorac Surg 2010; 90:1025-1027.
17. Cox G, Miller JD, McWilliams A, Fitzgerald JM, Lam S. Bronchial thermoplasty for asthma. Am J Respir Crit Care Med 2006; 173:965-969.
18. Cox PG, Miller J, Mitzner W, Leff AR. Radiofrequency ablation of airway smooth muscle for sustained treatment of asthma: preliminary investigations. Eur Respir J 2004; 24:659-663.
19. Wise RA, Bartlett SJ, Brown ED, et al; American Lung Association Asthma Clinical Research Centers. Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. J Allergy Clin Immunol 2009; 124:436-444.
20. Castro M, Rubin A, Laviolette M, Hanania NA, Armstrong B, Cox G; AIR2 Trial Study Group. Persistence of effectiveness of bronchial thermoplasty in patients with severe asthma. Ann Allergy Asthma Immunol 2011. doi:10.1016/j.anai.2011.03.005.
21. Thomson NC, Rubin AS, Niven RM, et al; AIR Trial Study Group. Long-term (5year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial. BMC Pulm Med 2011; 11:8.
22. Solway J, Irvin CG. Airway smooth muscle as a target for asthma therapy. N Engl J Med 2007; 356:1367-1369.
23. Ingram RH Jr, McFadden ER Jr. Localization and mechanisms of airway responses. N Engl J Med 1977; 297:596-600.
24. Dyrda P, Tazzeo T, DoHarris L, et al. Acute response of airway muscle to extreme temperature includes disruption of actin-myosin interaction. Am J Respir Cell Mol Biol 2011; 44:213-221.
25. Mayse ML, Laviolette M, Rubin AS, et al. Clinical pearls for bronchial thermoplasty. J Bronchol 2007; 14:115-123.